EUVIMEDEUVIMED entdecken
Crossref

Decoding Inhibitor Egression from Wild-Type and G2019S Mutant LRRK2 Kinase: Insights into Unbinding Mechanisms for Precision Drug Design in Parkinson’s Disease

Avigyan Naskar, Rakesh K Roy, Diship Srivastava iD, Niladri Patra iD

The Journal of Physical Chemistry B · 2024

DOI: 10.1021/acs.jpcb.4c00335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Physical Chemistry B, 2024. Verfasst von Avigyan Naskar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Chemical Biology, Indian Institute of Technology (ISM) Dhanbad, Dhanbad 826004, India. Hauptthemen laut MEDLINE: Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Parkinson Disease, Protein Kinase Inhibitors, Drug Design. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: Science and Engineering Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2Parkinson DiseaseProtein Kinase InhibitorsDrug DesignMolecular Dynamics SimulationMutationHumansIndazolesPyrimidines

Substanzen

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2Protein Kinase InhibitorsLRRK2 protein, human2,6-dimethyl-4-(6-(5-(1-methylcyclopropoxy)-1H-indazol-3-yl)pyrimidin-4-yl)morpholineIndazolesPyrimidines

Autor:innen und Institutionen

  • Department of Chemistry and Chemical Biology, Indian Institute of Technology (ISM) Dhanbad, Dhanbad 826004, India.

ORCID-Profile: Diship Srivastava, Niladri Patra

Förderung

  • Science and Engineering Research Board

Zitieren

APA

Naskar, A., Roy, R. K., Srivastava, D., & Patra, N. (2024). Decoding Inhibitor Egression from Wild-Type and G2019S Mutant LRRK2 Kinase: Insights into Unbinding Mechanisms for Precision Drug Design in Parkinson’s Disease. The Journal of Physical Chemistry B. https://doi.org/10.1021/acs.jpcb.4c00335

Vancouver

Naskar A, Roy RK, Srivastava D, Patra N. Decoding Inhibitor Egression from Wild-Type and G2019S Mutant LRRK2 Kinase: Insights into Unbinding Mechanisms for Precision Drug Design in Parkinson’s Disease. The Journal of Physical Chemistry B. 2024. doi:10.1021/acs.jpcb.4c00335

BibTeX
@article{Naskar2024,
  author = {Naskar, Avigyan and Roy, Rakesh K and Srivastava, Diship and Patra, Niladri},
  title = {Decoding Inhibitor Egression from Wild-Type and G2019S Mutant LRRK2 Kinase: Insights into Unbinding Mechanisms for Precision Drug Design in Parkinson’s Disease},
  journal = {The Journal of Physical Chemistry B},
  year = {2024},
  doi = {10.1021/acs.jpcb.4c00335}
}
Kostenlos starten →